logo

Inovio Pharmaceuticals Inc. (INO)



Trade INO now with
  Date
  Headline
1/6/2021 8:02:24 AM INOVIO Announces Positive Efficacy Results For An Open-label Phase 2 Trial Of VGX-3100
1/4/2021 8:06:54 AM INOVIO And Advaccine Enter Collaboration And License Agreement For COVID-19 DNA Vaccine Candidate INO-4800
12/24/2020 9:20:21 AM INOVIO : Phase 1 Data Shows COVID-19 DNA Vaccine Candidate INO-4800 Immunogenic In All Vaccinated Subjects
12/15/2020 8:03:29 AM INOVIO To Develop DMAb Candidates To Treat COVID-19 With Funding From DARPA And DoD JPEO-CBRND
12/10/2020 8:02:11 AM INOVIO, Advaccine Report First Dosing Of Subject In Phase 2 Trial For COVID-19 DNA Vaccine Candidate INO-4800 In China
12/9/2020 8:04:46 AM INOVIO: VGX-3100 Show Positive Phase 2 Efficacy In Treatment Of Precancerous Anal Dysplasia Caused By HPV-16/18
12/7/2020 8:04:42 AM INOVIO Doses First Subject In Phase 2 Clinical Trial Evaluating DNA Medicine INO-4800
12/3/2020 8:08:34 AM INOVIO Expands Manufacturing Consortium For COVID-19 Vaccine Candidate INO-4800 With Addition Of Kaneka
11/23/2020 8:01:51 AM INOVIO Announces Dosing Of First Subject In Phase 1/2 Clinical Trial For INO-3107
11/20/2020 8:04:06 AM INOVIO To Present Data From Novel Combination Trial Of DNA Medicines INO-5401 And INO-9012 Plus PD-1 Inhibitor Libtayo